125 related articles for article (PubMed ID: 24786485)
1. Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates.
Li L; Liu Y; Wang J; Chen L; Zhang W; Yan X
Drug Deliv; 2016; 23(1):79-87. PubMed ID: 24786485
[TBL] [Abstract][Full Text] [Related]
2. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.
Chen L; Wang Y; Zhang J; Hao L; Guo H; Lou H; Zhang D
Eur J Pharm Biopharm; 2014 May; 87(1):160-9. PubMed ID: 24333772
[TBL] [Abstract][Full Text] [Related]
3. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
[TBL] [Abstract][Full Text] [Related]
4. Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system.
Qi L; Guo Y; Luan J; Zhang D; Zhao Z; Luan Y
J Mater Chem B; 2014 Dec; 2(47):8361-8371. PubMed ID: 32262006
[TBL] [Abstract][Full Text] [Related]
5. Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer.
Wang Y; Rong J; Zhang J; Liu Y; Meng X; Guo H; Liu H; Chen L
Drug Dev Ind Pharm; 2017 Jan; 43(1):132-141. PubMed ID: 27588517
[TBL] [Abstract][Full Text] [Related]
6. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
7. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy.
Kurakula M; El-Helw AM; Sobahi TR; Abdelaal MY
Int J Nanomedicine; 2015; 10():321-34. PubMed ID: 25609947
[TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
9. Nanoformulation of dual bexarotene-tailed phospholipid conjugate with high drug loading.
He R; Du Y; Ling L; Ismail M; Hou Y; Yao C; Li X
Eur J Pharm Sci; 2017 Mar; 100():197-204. PubMed ID: 28088372
[TBL] [Abstract][Full Text] [Related]
10. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
11. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
[TBL] [Abstract][Full Text] [Related]
13. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
[TBL] [Abstract][Full Text] [Related]
14. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
[TBL] [Abstract][Full Text] [Related]
15. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
17. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX
Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
Zhang J; Lv H; Jiang K; Gao Y
Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
